作者: David Bates
DOI:
关键词:
摘要: The use of an agent which selectively inhibits, prevents or interferes with the signal transduced by flk-1/KDR when activated a ligand, in manufacture medicament for treatment lymphoedema and method reducing filtration rate from blood to tissue. Also provided is identifying compounds useful lymphoedema, identified thereby.